Skip to main content

VOXZOGO 0.4mg, VOXZOGO 0.56mg, VOXZOGO 1.2mg

Unverified·never
Manufacturer
BioMarin
ICD-10 indication
Q77.4

Affordability Check

How much will you actually pay for VOXZOGO 0.4mg, VOXZOGO 0.56mg, VOXZOGO 1.2mg?

In 30 seconds, see every legitimate way to afford VOXZOGO 0.4mg, VOXZOGO 0.56mg, VOXZOGO 1.2mg — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About VOXZOGO 0.4mg, VOXZOGO 0.56mg, VOXZOGO 1.2mg

What is this medication?

Voxzogo, featuring the active ingredient vosoritide, is a prescription medicine intended to increase linear growth in pediatric patients with achondroplasia. Achondroplasia is a genetic condition and the most frequent cause of short-limbed dwarfism. This medication is specifically designed for children whose growth plates remain open, meaning they still have the biological capacity for skeletal growth.

The medication functions as a C-type natriuretic peptide analog that works by promoting bone formation through the regulation of specific signaling pathways. It is provided in several strengths, including 0.4mg, 0.56mg, and 1.2mg, and is administered as a once-daily injection under the skin. By stimulating the growth plates, the treatment helps to improve the rate of height increase in children as they develop.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Yes

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

VOXZOGO 0.4mg, VOXZOGO 0.56mg, VOXZOGO 1.2mg treats a rare condition. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.